- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Audubon Today
By the People, for the People
Globus Medical Shares Sold by Exchange Traded Concepts
Institutional investor reduces stake in medical device company
Mar. 29, 2026 at 7:52am
Got story updates? Submit your updates here. ›
Exchange Traded Concepts LLC, an institutional investor, reduced its position in Globus Medical, Inc. (NYSE:GMED) by 13.6% in the fourth quarter, according to a recent SEC filing. The firm now owns 202,419 shares of the medical device company's stock, valued at $17,673,000.
Why it matters
Globus Medical is a leading manufacturer of spinal implants and surgical instruments. Institutional ownership and trading activity can provide insights into market sentiment and the overall performance of the company.
The details
Exchange Traded Concepts sold 31,803 shares of Globus Medical stock during the fourth quarter, reducing its total stake to 202,419 shares. The firm previously owned about 0.15% of the company's outstanding shares.
- Exchange Traded Concepts filed the SEC report in the 4th quarter of 2026.
The players
Exchange Traded Concepts LLC
An institutional investor that manages exchange-traded funds and other investment products.
Globus Medical, Inc.
A leading medical device company that specializes in musculoskeletal solutions for spine and orthopedic applications.
The takeaway
The reduction in Globus Medical's institutional ownership by Exchange Traded Concepts suggests that the investment firm may have a more cautious outlook on the company's near-term prospects, though Globus Medical remains a well-regarded player in the medical device industry.
